These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29 related articles for article (PubMed ID: 2572202)
1. Estrogen receptor- and progesterone receptor-positive breast tumors have higher mRNA levels of NR3C1 and ZBTB16, with implications in prognosis for luminal A subtype. Berkel C Hum Cell; 2024 Jan; 37(1):376-379. PubMed ID: 37999919 [No Abstract] [Full Text] [Related]
2. [C-erbB-2 oncogene amplification in breast cancer in correlation to steroid and epidermal growth factor receptor]. Manavi M; Czerwenka KF; Zeillinger R; Speiser P; Kury F; Steinhart U; Peschke M; Kubista E; Reinold E Zentralbl Gynakol; 1992; 114(2):82-5. PubMed ID: 1350129 [TBL] [Abstract][Full Text] [Related]
3. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology]. Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430 [No Abstract] [Full Text] [Related]
5. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer]. Sellami M; Gamoudi M; Krichen K; Kharrat A; Ben Romdhane K; Maalej M Arch Inst Pasteur Tunis; 1991; 68(1-2):33-41. PubMed ID: 1687309 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features. Lönn U; Lönn S; Nilsson B; Stenkvist B Breast Cancer Res Treat; 1994; 29(3):237-45. PubMed ID: 7914106 [TBL] [Abstract][Full Text] [Related]
7. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Slamon DJ; Clark GM; Wong SG; Levin WJ; Ullrich A; McGuire WL Science; 1987 Jan; 235(4785):177-82. PubMed ID: 3798106 [TBL] [Abstract][Full Text] [Related]
8. [Oncogene organization and expression in breast cancer exemplified by proto-oncogene c-erb B2]. Friedrichs K; Jonat W; Meybohm J; Singh S Arch Gynecol Obstet; 1989; 245(1-4):658-60. PubMed ID: 2572202 [No Abstract] [Full Text] [Related]
9. Correlation of erbB-2 gene amplification with low levels of estrogen and/or progesterone receptors in primary breast cancer: do erbB-2 products delineate hormone-independent tumors? Roux-Dosseto M; Romain S; Dussault N; Martin PM Biomed Pharmacother; 1989; 43(9):641-9. PubMed ID: 2696563 [TBL] [Abstract][Full Text] [Related]
10. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene. Singleton TP; Strickler JG Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551 [TBL] [Abstract][Full Text] [Related]
11. c-erbB-2 oncogene as a prognostic marker in breast cancer. Perren TJ Br J Cancer; 1991 Mar; 63(3):328-32. PubMed ID: 1672251 [No Abstract] [Full Text] [Related]
12. The role of molecular analysis in breast cancer. Geyer FC; Marchio C; Reis-Filho JS Pathology; 2009 Jan; 41(1):77-88. PubMed ID: 19089743 [TBL] [Abstract][Full Text] [Related]